USPTO serial 79384704
DIASORIN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 29, 2024
- Examiner
- GREEN, ASHLEY ELIZABETH
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with DIASORIN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ben Natter
Ben Natter HAUG PARTNERS, LLP745 FIFTH AVENUENEW YORK, NY 10151United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in science; Diagnostic biomarkers for use in the assessment of infectious diseases for analytical, research and scientific use; Diagnostic kits comprised of specimen receptors and medical diagnostic reagents for testing for selected bacteria; Diagnostic testing materials, namely, preparations and reagents for scientific use and research use other than for medical purposes; Chemical reagent mixtures, other than for medical or veterinary use; Diagnostic preparations for use in assessment of toxicological property of chemical compounds and mixture, for scientific use; Diagnostic chemicals for use in antibiotic susceptibility testing for scientific research use, other than for medical purposes; Diagnostic preparations for research laboratory use; Diagnostic preparations for in vitro testing, for scientific use; Chemical reagents for molecular biology, other than for medical or veterinary purposes; Chemical reagents for use in analytical tests, other than for medical or veterinary purposes; Chemical reagents in kit form for conducting immunosorbent assays for scientific purposes; Chemical reagents, namely, solutions used in diagnostic test kits for laboratory or research purposes; Diagnostic substances for scientific or research use, other than for medical purposes; Reagent bearing diagnostic test strips for testing blood samples and body fluids; Chemically treated non-medical test strips for laboratory or research purposes; Reagent paper, other than for medical or veterinary purposes; Cultures of microorganisms, other than for medical or veterinary use; Preparations of microorganisms, other than for medical or veterinary use; Bacterial preparations, other than for medical or veterinary use; Bacteriological preparations, other than for medical or veterinary use; Biological preparations, other than for medical or veterinary purposes; Chemical substances for analyses in laboratories, other than for medical or veterinary purposes; Chemical reagents, other than for medical or veterinary purposes; Reagents for chemical analyses; Diagnostic reagents for scientific use; Biochemical reagents used for non-medical purposes; Diagnostic reagents, other than for medical laboratory use; Diagnostic reagents and preparations not for medical or veterinary purposes; Reagents for use in scientific apparatus for chemical or biological analysis; Cell culture reagents for scientific and research use | ACTIVE | — |
| 005 | Chemical reagents for medical or veterinary purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic agents for pharmaceutical use; Diagnostic agents for medical, clinical and pharmaceutical purposes; Diagnostic agents for medical use; Diagnostic test kits consisting primarily of medical diagnostic reagents for detecting antibodies, enzymes, antigens, diseases, viruses and infections, for medical and clinical purposes; Diagnostic reagents for serologic tests of infections for medical and clinical purposes; Diagnostic kits comprised of bioreagents for use in disease testing; Diagnostic test kits comprised of reagents and assays for testing body fluids; In vitro diagnostic test kit comprised of medical diagnostic reagents for testing of body fluids; Diagnostic testing materials for medical use in the form of reagent paper for measuring antibodies and blood cells; Biochemical preparations for medical or veterinary purposes for treating respiratory syndromes; Bacterial preparations for medical or veterinary use; Reagents and medical diagnostic test strips for detecting nucleic acid targets and indicators of disease, namely, enzymes, antigens, antibodies and nucleic acids; Medical diagnostic reagents and assays for testing of body fluids; Immunoassay reagents for medical use; Diagnostic preparations for in vitro testing for medical use; Medical diagnostics testing for the detection, diagnosis, analysis, and confirmation of viruses and infections; Medical diagnostic testing in antibody detection; Reagent paper for medical purposes; Cultures of microorganisms for medical or veterinary use; Preparations of microorganisms for medical or veterinary purposes; Bacteriological preparations for medical or veterinary use; Diagnostic preparations for medical purposes; Diagnostic reagents for medical use; Biological and chemical diagnostic reagents for medical or veterinary purposes; Diagnostic reagents for medical or veterinary purposes; Diagnostic reagents for medical purposes; Diagnostic preparations for medical or veterinary purposes; In vitro diagnostic preparations for medical use; Swabs and diagnostic preparations for medical and medical diagnostic use; Nasopharyngeal swabs for medical use; Chemico-pharmaceutical preparations for medical diagnostic use; Pharmaceuticals for use in the diagnosis of infectious diseases; Pharmaceutical, medical diagnostic and veterinary preparations for use in the diagnosis of infectious diseases; Disinfectants; Dietetic substances being food and beverages adapted for medical use | ACTIVE | — |
| 009 | Semiconductor testing apparatus; Laboratory apparatus, namely, analyzers for measuring and analyzing blood and other bodily fluids; Scientific research specimen collection devices in the nature of tubes, swabs and bags for the collection of blood, urine and fecal matter; Data processing equipment, namely, optical readers for diagnostic purposes other than for medical use; Measuring or testing machines and instruments for diagnostic purposes, other than for medical use, namely, apparatus composed of PC tablets and optical readers for testing liquids and solids; Downloadable portable and cloud-connected point of care (POC) immunodiagnostic software platforms for diagnostic research and scientific use; Computer software and hardware for the design, creation and testing of medical diagnostic instruments; Downloadable software for processing data; diagnostic apparatus for the detection of cancer; computer hardware and computers; Downloadable computer software using artificial intelligence for use in software development in the field of healthcare; Downloadable computer software for medical diagnostics; Tablet computers for testing and diagnostic purposes; Diagnostic apparatus for the detection of pathogens, not for medical purposes; Disposable dispenser syringes for laboratory use; Downloadable computer software applications for diagnosing illnesses; Scientific apparatus and instruments other than for medical purposes for immunological analysis and diagnostics; Downloadable computer software for diagnosing illnesses; Computer software platforms, downloadable, for diagnosing illnesses; Computer software platforms, recorded, for diagnosing illnesses; Downloadable computer programs for diagnosing illnesses in the diagnostic field; Laboratory robots; Pathogen measurement and blood analysis machines and equipment for use in diagnosing illnesses; Downloadable software for processing and interpreting data in the field of medical and veterinary diagnostics | ACTIVE | — |
| 010 | Surgical apparatus and instruments for medical, pharmaceutical and veterinary diagnostic use; Diagnostic apparatus for the identification of infectious diseases; Diagnostic imaging apparatus for medical use; Diagnostic apparatus for identifying antibodies against the SARS-CoV-2 virus in capillary blood samples; Medical diagnostic apparatus for testing antigens for COVID-19 diagnosis; Medical diagnostic apparatus for testing molecular cells for COVID-19 diagnosis; Medical diagnostic apparatus for testing DNA and RNA samples for medical purposes; Medical diagnostic instruments for the analysis of body fluid samples; Blood testing apparatus, namely, blood sampling tubes; Genetic testing apparatus for medical purposes; Diagnostic apparatus for medical purposes used in medical laboratories for testing DNA; Point of care (POC) immunochemical testing apparatus for carrying-out diagnostic tests for medical purposes; Laboratory apparatus for medical diagnostic purposes in the nature of liquid- and cell- dispensing devices for analyzing and investigating cells; Medical devices for medical diagnostic, examination and monitoring in clinical application sectors, namely, point of care diagnostic, examination and monitoring devices for ascertaining clinically relevant measurement of analyte concentration in whole blood and blood plasma; Diagnostic medical apparatus for testing samples of DNA and RNA; Saliva collection devices for medical diagnostic purposes in the nature of saliva vials; Extraction syringes for medical purposes; Injection syringes; Analysers for bacterial identification for medical purposes; Blood testing apparatus; Medical diagnostic apparatus for testing for viruses | ACTIVE | — |
| 042 | Updating of computer software in the medical diagnostic field; Design and development of computer software in the medical diagnostic field; Rental of computer software for medical diagnostic purposes; Maintenance and repair of computer software in the medical diagnostic field; Design and development of computer hardware in the medical diagnostic field; Design and development of software and hardware in the medical diagnostic field; Scientific research and development in the field of biotechnology; Research and development in the field of medical diagnostic preparations; Biological research; Chemical research; Scientific research; Computer aided medical diagnostic testing services; Scientific laboratory services; Chemical analysis; Installation of computer software for use in the medical diagnostic field; Bacteriological research; Stem cell research services and laboratory testing of materials | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by DIASORIN S.P.A.
- Other trademarks owned by DIASORIN S.P.A.
- Other trademarks owned by DIASORIN S.P.A.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named DIASORIN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 25, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 24, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 6, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 6, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Apr 19, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 2, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 2, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 29, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 29, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 29, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 13, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 13, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 24, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 10, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 10, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 10, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 10, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 10, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 8, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 8, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 8, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 8, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 12, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 11, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 24, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 23, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 13, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 12, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 8, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 7, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |